Evidence map›Paper›PMID 40705427›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Epigenetic instability and hypofunctionality of fetal Tregs allow a permissive regulatory environment for T effector memory maturation.

Jing Yao Leong, Naomi McGovern, Archita Mishra, Martin Wasser, Pavanish Kumar, Shi Huan Tay, Sharifah Nur Hazirah, Joo Guan Yeo, Xiu Qi Tan, Nursyuhadah Sutamam and 16 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Jing Yao Leong *Translational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.ORCID 0000-0002-8651-9801
Naomi McGovern *Centre for Trophoblast Research, Department of Pathology, University of Cambridge, Cambridge CB2 1QP, United Kingdom.
Archita Mishra *Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
Martin Wasser *Translational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.
Pavanish KumarTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.ORCID 0000-0003-1832-4436
Shi Huan TayTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.ORCID 0000-0002-3341-5427
Sharifah Nur HazirahTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.ORCID 0000-0003-4636-6430
Joo Guan YeoTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.
Xiu Qi TanTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.
Nursyuhadah SutamamTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.
Farah Nadiah AzmanTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.
Camillus Jian Hui ChuaTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.
Phyllis ZiXuan ChenTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.
Fauziah AllyTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.
Charles-Antoine DutertreGustave Roussy Cancer Campus, Villejuif 94800, France.
Lakshmi RamakrishnaTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.
Su Li PohTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.
Liang XieTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.
Yiping FanDepartment of Reproductive Medicine, KK Women's and Children's Hospital, Singapore 229899, Singapore.
Catherine DonnerDepartment of Obstetrics and Gynecology, Hôpital Erasme, Université Libre de Bruxelles, Brussels 1070, Belgium.ORCID 0000-0002-2090-4977
Maria PapadopoulouDepartment of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles, Brussels 1050, Belgium.ORCID 0000-0002-3006-1993
David VermijlenDepartment of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles, Brussels 1050, Belgium.ORCID 0000-0002-7605-8845
Thaschawee ArkachaisriTranslational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.
Jerry Kok Yen Chan *Department of Reproductive Medicine, KK Women's and Children's Hospital, Singapore 229899, Singapore.
Florent Ginhoux *Translational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.ORCID 0000-0002-2857-7755
Salvatore Albani *Translational Immunology Institute, Singhealth/Duke-National University of Singapore, Academic Medical Centre, The Academia, Singapore 169856, Singapore.ORCID 0000-0002-5602-6256

Funding

A*STAR | Biomedical Research Council (BMRC) H22P0M0003Human Frontier Science Program (HFSP) LT000363/2019-LMOH | National Medical Research Council (NMRC) NMRC/OFLCG/002/2018 CIRG19may0052 NMRC/CSA-SI/008/2016 NMRC/C-IRG/1484/2018; NMRC/CG/M003/2017 MWellcome TrustWellcome Trust (WT) 204464/Z/16/Z
6 · The paper itself

Abstract

The human gestational environment is commonly perceived to be predominantly suppressive and incompatible for T effector maturation. However, evidence of a competent effector fetal environment is mounting in the field. Here, we employed a high parametric, mass cytometry-based approach to study the fetal circulatory and microenvironmental immunomes, with the aim to understand the inception and extent of fetal effector T cell priming and its relation with regulatory mechanisms. We found evidence of fetal thymic immune imprinting, coupled with both circulatory and tissue effector memory development. Correspondingly, in the regulatory compartment, we detected the presence of Tbet

Indexed as

Epigenesis, GeneticFetusImmunologic MemoryT-Lymphocytes, RegulatoryAdultFemaleForkhead Transcription FactorsHumansPregnancyThymus GlandForkhead Transcription FactorsFOXP3 protein, humanhuman fetal tissueimmunomicsmass cytometrythymic imprintingT regulatory cells

Identifiers

PMID40705427
PMCPMC12318238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.